X-206 exhibits broad-spectrum anti-β-coronavirus activity, covering SARS-CoV-2 variants and drug-resistant isolates.
Sasaki J, Sato A, Sasaki M, Okabe I, Kodama K, Otsuguro S, Yasuda K, Kojima H, Orba Y, Sawa H, Maenaka K, Yanagi Y, Hashiguchi T.
Sasaki J, et al. Among authors: sato a.
Antiviral Res. 2024 Nov 19;232:106039. doi: 10.1016/j.antiviral.2024.106039. Online ahead of print.
Antiviral Res. 2024.
PMID: 39571911